Click to copy
Click to copy

Aeglea: 2Q Earnings Snapshot

August 6, 2019

AUSTIN, Texas (AP) _ Aeglea Biotherapeutics Inc. (AGLE) on Tuesday reported a loss of $18 million in its second quarter.

The Austin, Texas-based company said it had a loss of 55 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 50 cents per share.

Aeglea shares have increased almost 9% since the beginning of the year. The stock has fallen nearly 9% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGLE at https://www.zacks.com/ap/AGLE

All contents © copyright 2019 The Associated Press. All rights reserved.